Richard Harrop
Windrush Court, Transport Way
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 17, 2024
Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia.
Journal: Molecular cancer therapeutics
Published: January 28, 2024
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2020
Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
Journal: Therapeutic advances in vaccines and immunotherapy
Published: August 23, 2018
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 15, 2017
A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial.
Journal: Oncoimmunology
Published: November 28, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 08, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 27, 2017
Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.
Journal: Human gene therapy
Published: October 07, 2016
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: July 06, 2016
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Journal: Lancet (London, England)
Published: January 14, 2014
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trial.
Journal: Cancer immunology, immunotherapy : CII
Published: May 28, 2013
Last Updated: 09/26/2026